Your browser is unsupported

We recommend using the latest version of IE11, Edge, Chrome, Firefox or Safari.

Division of Hematology and Oncology Recent Grants & Awards

Active Research Support

Clinical Trials

Santosh Saraf, MD Heading link

  • R01 (PI) “Pathways of Cell-free hemoglobin in Sickle Cell Nephropathy”
  • R01 (MPI) “Predicting Progression of Chronic Kidney Disease in Sickle Cell Anemia Using Machine Learning Models”
  • R01 (CoI) “Improving Scientific Rigor of Clinical Endpoints for Sickle Cell Anemia”
  • R01 (CoI) “Molecular and Cellular Pathogenesis of Kidney Disease in Sickle Cell Disorders”
  • U54 (Project Co-Leader) H3 Africa: Sickle Cell Disease Nephropathy
    Global Blood Therapeutics (IIT PI) “A pilot study of Voxelotor for Sickle Cell anemia Patients at Highest Risk for Progression of Kidney Disease”
  • Novartis (IIT PI) “Clinical, Laboratory, and Genetic Predictors for Sickle cell Nephropathy”

Sean Quigley, MD Heading link

  • 2U54DK083909-11, (Desnick (PI)), $1.4 M/year, 08/2019–08/2024
    Agency: NIDDK, Porphyria Consortium
    Clinical research support for porphyria studies (Satellite site PI, clinical research coordinator support)
  • ACTIV-4 Program for COVID-19 patients, Krishnan (PI), $6M (est)., 09/2020–06/2022
    Agency: NIH/NHLBI
    Role: Co-Investigator (0.15 FTE).
  • ACTIV-4a, 4c studies, Quigley, J (PI, Illinois), ~$3M (est; ~$1M accrued to date), 09/2020–12/2022.
    Agency: NIH/NHLBI
    Roles: PI for both these In-Hospital and Post-Hospital discharge anticoagulation trials for COVID-19 patients, 2.4 cal. months
  • ACTIV-4 Program ILLI-NET award, Quigley (Co-PI), $3M (est).
    Agency: NIH/NHLBI
    Roles: Co-PI for both ACTIV-4a, -4c Illinois Hospitals Networks, 1.2 cal. months
  • OTA-21-015B, Post-Acute Sequelae of SARS-CoV-2 Infection, Krishnan (PI), 09/2021–09/2025, est. $20M
    Agency: NIH
    Role: Co-I, Hematology/Thrombosis clinical research aspects, for UIC and for ILLI-NET, 1.2 cal. Months
  • ACTIV-4d, Collins, ~$200K to UIC (est), 06/2021–06/2022
    Agency: NIH/NHLBI
    Role: PI for UIC, RAAS trial for COVID-19 patients, 1.2 cal. months

Kent Hoskins, MD Heading link

  • American Cancer Society
    (Kitajewski-Center PI; Hoskins, PI of Research Scholar Grant Project 3)
    Project title: Illinois Cancer Health Equity Research Center
    Research Scholar Grant Project 3 title: Creation of a Culturally Sensitive Narrative Intervention to Promote Equity in Clinical Trials Participation.
    Grant number: K01CA248852 (Henderson)
    Project title: Promoting Genetic Counseling among African American Women with Hereditary Risk for Breast Cancer
    Role: UIC sub-award Principal Investigator
  • American Heart Association (PI, Beyer)
    Project title: “Taking Charge During Treatment: exercise to improve fitness and quality of life among diverse breast cancer survivors”
    Role: Co-Investigator
    Department of Defense Breakthrough Award (Hoskins, PI)
    Project title: “Therapeutic Benefit of Potassium Channel Activators in Triple-Negative Breast Cancer.”
    Role: Partnering Principal Investigator
    NIH/NCI (Raychaudhuri, PI)
    Project title: Repression function of FoxM1 in tumor metastasis
    Role: Co-Investigator